CoChat

Comparisons of diabetic retinopathy events associated with glucose‐lowering drugs in patients with type 2 diabetes mellitus: A network meta‐analysis

Open access
Tang, Huilin, Li, Guangyao, Zhao, Ying, Wang, Fei, Gower, Emily W., Shi, Luwen, Wang, Tiansheng · 2018 · Diabetes, Obesity and Metabolism
Cited by 78

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Aim: To assess the comparative effects of glucose‐lowering drugs (GLDs) on the risk of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM). Methods: We systematically searched Cochrane Central Register of Controlled Trials, PUBMED and EMBASE from inception to January 17, 2017 to identify randomized controlled trials (RCTs) that reported DR events among T2DM patients receiving any GLD. Random‐effects pairwise and network meta‐analyses were performed to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Results: A total of 37 independent RCTs with 1806 DR events among 100 928 patients with T2DM were included. The mean duration of diabetes was 8.7 years and mean baseline HbA1c was 8.2% (SD, 0.5%). Our network meta‐analysis found that DPP‐4i (OR, 1.20; 95% CI, 0.87‐1.65), GLP‐1RA (OR, 1.19; 95% CI, 0.94‐1.52) and SGLT2 inhibitors (OR, 0.79; 95% CI, 0.49‐1.28) were not associated with a higher risk of DR than placebo; however, a significantly increased risk of DR was associated with DPP‐4i in the pairwise meta‐analysis (OR, 1.27; 95% CI, 1.05‐1.53). Sulfonylureas, on the other hand, were associated with a significantly increased risk of DR compared to placebo (OR, 1.67; 95% CI, 1.01‐2.76). Conclusions: Current evidence indicates that the association between DPP‐4i, GLP‐1RA or SGLT2 inhibitors and risk of DR remains uncertain in patients with T2DM. Some evidence suggests that sulfonylureas may be associated with increased risk of DR. However, given that DR events were not systematically assessed, these effects should be explored further in large‐scale, well‐designed studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.13232

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 52

  1. 10.2337/dc12-0863 · DOI · Paper page
  2. 10.1001/jama.298.8.902 · DOI · Paper page
  3. 10.1056/NEJM199309303291401 · DOI · Paper page
  4. 10.1136/bmj.321.7258.405 · DOI · Paper page
  5. 10.1056/NEJMoa0806470 · DOI · Paper page
  6. 10.2337/dc16-2641 · DOI · Paper page
  7. 10.1016/j.ajo.2008.10.016 · DOI
  8. 10.1001/archinternmed.2012.1938 · DOI · Paper page
  9. 10.1016/j.lfs.2016.01.042 · DOI
  10. JPT H, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 510
  11. 10.1002/sim.1186 · DOI · Paper page
  12. 10.1038/ajg.2008.22 · DOI · Paper page
  13. 10.1056/NEJMoa1612917 · DOI · Paper page
  14. 10.1111/j.1464-5491.2011.03387.x · DOI · Paper page
  15. 10.1007/s40261-013-0107-8 · DOI
  16. 10.2337/dc12-2718 · DOI · Paper page
  17. 10.2337/dc12-1365 · DOI · Paper page
  18. 10.1007/s00125-015-3795-1 · DOI · Paper page
  19. 10.1111/j.2040-1124.2011.00128.x · DOI · Paper page
  20. 10.1111/dom.12188 · DOI · Paper page
  21. 10.1016/S0140-6736(13)60683-2 · DOI · Paper page
  22. 10.1016/S2213-8587(14)70120-2 · DOI · Paper page
  23. 10.1111/j.1463-1326.2011.01385.x · DOI · Paper page
  24. 10.2337/dc13-2855 · DOI · Paper page
  25. 10.1111/dom.12540 · DOI · Paper page
  26. 10.2337/dc14-0876 · DOI · Paper page
  27. 10.1007/s00125-014-3360-3 · DOI
  28. 10.1016/S0140-6736(09)60953-3 · DOI · Paper page
  29. 10.1111/1753-0407.12357 · DOI
  30. 10.1111/jdi.12457 · DOI · Paper page
  31. 10.1111/dom.12121 · DOI · Paper page
  32. 10.1111/j.2040-1124.2011.00103.x · DOI
  33. 10.2337/dc14-0001 · DOI · Paper page
  34. 10.1016/S0140-6736(10)60307-8 · DOI · Paper page
  35. 10.2337/dc14-0024 · DOI · Paper page
  36. 10.1016/j.bbadis.2014.04.013 · DOI
  37. 10.1111/j.1463-1326.2011.01548.x · DOI
  38. 10.1167/iovs.15-19006 · DOI · Paper page
  39. 10.1007/s00125-017-4388-y · DOI
  40. 10.1186/1475-2840-13-19 · DOI
  41. 10.1186/1475-2840-12-59 · DOI
  42. 10.1161/ATVBAHA.116.307930 · DOI
  43. 10.2337/db16-1364 · DOI · Paper page
  44. 10.1016/j.diabres.2013.12.041 · DOI
  45. 10.1016/j.diabres.2011.08.017 · DOI
  46. 10.1186/s12933-017-0510-1 · DOI · Paper page
  47. 10.1038/ki.2014.246 · DOI
  48. 10.1016/S2213-8587(14)70256-6 · DOI
  49. 10.1056/NEJMoa0802987 · DOI · Paper page
  50. 10.1007/s00125-009-1457-x · DOI · Paper page
  51. 10.1001/archophthalmol.2009.310 · DOI
  52. Gower EW, 2017, Lack of longitudinal association between thiazolidinediones and incidence and progression of diabetic eye disease: the ACCORD EYE Study, Am J Ophthalmol

Cited by

See all 78

Metadata

Authors
Tang, H., Li, G., Zhao, Y., Wang, F., Gower, E. W., Shi, L., & Wang, T.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2018-02-23
Volume
20
Issue
5
Pages
1262-1279
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2789501881
Cited by
78
References
20
FWCI
3.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.